Navigation Links
Axsun Technologies Announces Exclusive Cardiac Supply Agreement for Advanced OCT Tunable Lasers with LightLab Imaging
Date:6/2/2008

BILLERICA, Mass., June 2 /PRNewswire/ -- Axsun Technologies Inc., a leading developer and manufacturer of advanced photonic components and subsystems, today announced that the company has entered into a multi-million dollar volume purchasing agreement with LightLab imaging. Under this multi- year exclusive agreement for cardiac Optical Coherence Tomography (OCT), Axsun will provide advanced tunable lasers for LightLab's next generation OCT imaging system.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080602/NEM077 )

"Swept Source OCT enables extremely high speed imaging with 10X higher imaging resolution than Ultrasound," noted Dale Flanders, CEO of Axsun Technologies, "Axsun's unique tunable laser technology provides unprecedented resolution, depth and speed of imaging in a compact and cost effective product offering that is simply not available from any other source."

"This agreement is the culmination of the successful joint development effort undertaken by the companies to design a product unique for OCT imaging," explained Joe Schmitt, Chief Technical Officer at LightLab. "The Axsun tunable laser solution provides a powerful combination of high performance, compact footprint, manufacturability and cost. We feel that this technology will address the requirements of our customers better than any other available offering."

About Axsun

Axsun Technologies, Inc., established in 1998, develops and manufactures advanced components and photonic subsystems used in industrial process control, test and measurement applications, and throughout the world's communication networks. Axsun has applied its expertise in micro-optics and precision engineering to pioneer an entirely new class of fully functional, miniaturized spectroscopic instruments and devices that enable dramatic improvements in quality, productivity, and performance across a variety of indus
'/>"/>

SOURCE Axsun Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
2. Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit, Oct. 1-3
3. VNUS Medical Technologies Announces Resignation of Chief Financial Officer and VP, Finance & Administration
4. Osteotech to Present at First Albany Capitals Regenerative Technologies Conference in New York
5. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
6. Advanced technologies aim to transform the coaching of top athletes
7. Global Med Technologies(R) Extends Its Worldwide Outreach
8. Acuo Technologies(R) Names Mike Dolan Vice President of Sales
9. ReBuilder Medical Technologies, Inc. Signs Agreement for Distribution in Maine
10. Neurobiological Technologies Reports Going Concern Qualification
11. MedCom USAs Subsidiary Card Activation Technologies, Inc.s SB2 Registration Declared Effective by SEC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)..., VIENNA, Va., Jan. 8 The Nationa...Inc., today announced the results of its organizat...on, President and CEO of Prematics, Inc., was elec...009 Board of Directors. The Collaborative builds ...rmation Community (AHIC), a federal advisory commi...
(Date:1/8/2009)..., , , Kelly Ripa Will Be Celebrity Host of S...Newswire/ -- Stand Up for a Cure today announced...ne,s Day show with Barry Manilow , in partnership... , The show will be held on February 14th, 2009 a...event go on sale Monday November 10th through Tick...
(Date:1/8/2009)..., WASHINGTON, Jan. 8 T...ability to plan and prepare for expensive long-ter...g to a new survey released today by America,s Heal...by StrategyOne on behalf of AHIP, found that 60 pe...ability to plan for future long-term care costs. ...
(Date:1/8/2009)...esearchers find it prolongs lives of key vision ce...Day News) -- Researchers working with mice have id...es of retinal cells in both healthy and diseased e...tments that would prevent blindness among people g... the scientists said. , The protein, known as h...
Breaking Medicine News(10 mins):Health News:Kevin Hutchinson Elected Vice Chair of Board of Directors for National eHealth Collaborative 2Health News:Barry Manilow Brings Valentine's and Music to New York With Concert to Raise Funds for Breast Cancer Research 2Health News:Economic Downturn Impacting Women's Ability to Plan for Long-Term Care Costs, New Survey Finds 2Health News:Economic Downturn Impacting Women's Ability to Plan for Long-Term Care Costs, New Survey Finds 3Health News:Protein Might One Day Prevent Blindness 2Health News:Protein Might One Day Prevent Blindness 3
...ikerwal, said today that the Government could save...get if it allowed GPs to refer patients directly f... of the proposal are contained in the AMA's Federa..., which was released yesterday. Dr Haikerwal sai...
...e banned from adding trans fatty acids to any food...aikerwal, said today. // 'The AMA believes the add...d out completely,' Dr Haikerwal said. 'In the mea...at have had trans fatty acids added to them should...
...men strongly about the side effects associated wit...er off //the development of severe blood clots in...ethinyl estradiol is available in the U.S with mor... in Canada. Use of this birth control patch has be...
...chool of Medicine have reported that genetics has ...rity (ROP) in preemies//, a disease known to hampe...nd could cause blindness. This report is published...“This is the first definitive study to show that g...
Other Medicine News:Health News:Genetics Plays A Crucial Role In Preemies' Destructive Eye Disease 2
(Date:1/8/2009)...rk,s second indication with clinical-stage, system..., FREMONT, Calif., Jan. 8 Quark Ph...tical company discovering and developing novel RNA...ounced that it has initiated patient dosing in its...ally administered siRNA drug candidate QPI-1002 (p...
(Date:1/8/2009)...Validate Novel Gene Expression Biomarkers Involved...Platform , , FREMONT, Calif., Jan. 8 /PRNewswir...letin Board: WGBS), a leading developer of state-o...y and stem cell research systems, today announced ...University of Texas Southwestern Medical Center f...
(Date:1/8/2009)... -- If you are taking prescription medicine,and f...the people taking,prescription medicine don,t tak...y forget, are busy with other priorities, or make ...en called the Achilles heel of modern,healthcare.... "Drugs don,t,work in people who don,t take them....
(Date:1/8/2009)...hio, Jan. 8 IntelligentMDx a develo...ssays, today announced that verification studies o...re complete. , , Under the verification protoc...and reproducibility and robustness of the BK Viral...in agreed with internally generated analytical per...
Breaking Medicine Technology:Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function 2Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function 3Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function 4WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 2WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 3WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 4WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 5Good Medicine: Smarter Smartphones for People With Chronic Disease 2Verification Studies of IntelligentMDx's Proprietary Molecular Diagnostic Assay Process Have Been Completed 2Verification Studies of IntelligentMDx's Proprietary Molecular Diagnostic Assay Process Have Been Completed 3Actress Continues Fight Against Hospital Errors 26 Rise in MRSA Cases 17204 1Actress Continues Fight Against Hospital Errors 26 Rise in MRSA Cases 17204 2Solar flares set the Sun quaking 2957 1Solar flares set the Sun quaking 2957 2HeartWare Announces Move to an Expanded Upgraded Manufacturing Facility 17200 1HeartWare Announces Move to an Expanded Upgraded Manufacturing Facility 17200 2HeartWare Announces Move to an Expanded Upgraded Manufacturing Facility 17200 3Osteotech Renews Tissue Recovery Agreement with the Euro Atlantic Transplant Alliance 4703 1Osteotech Renews Tissue Recovery Agreement with the Euro Atlantic Transplant Alliance 4703 2Osteotech Renews Tissue Recovery Agreement with the Euro Atlantic Transplant Alliance 4703 3
...and BASEL, Switzerland, June 27 /CNW/ -,Aspreva Ph... and,Roche today released preliminary results for ...olate mofetil, MMF) to intravenous,cyclophosphamid...r,inducing treatment response in the induction pha...though response rates were similar in both arms, t...
...IRE)--Jun 27, 2007 - Gentium S.p.A. (Nasdaq:,GENT)...reclinical,data that support the safety, activity,...brotide in combination with anticancer,therapy in ...update,from the Company,s ongoing Phase I/II clini... multiple myeloma with Defibrotide in,combination ...
Other Medicine Technology:Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 2Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 3Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 4Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 5Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 6Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 7Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 8Gentium's Defibrotide Seen as Active in Multiple Myeloma 2Gentium's Defibrotide Seen as Active in Multiple Myeloma 3
The MICROsed-System is the ideal system back up support to be used as front-line instrument with small workloads.
The Sedimat 15 Automated sedrate system provides an accurate ESR result in only 15 minutes. Fast, in-office results (before patient leaves the office) can lead to improved patient therapy.
...g device for finger and alternate site testing fro... Comfort Zone Technology and Force Adjustment that... Comfort Zone Technology increases comfort when la... pain. This approach masks the pain of lancing to ...
Reduce the pain and hassle of testing. Unlike conventional lancing systems, the ACCU-CHEK Multiclix lancet device is the only one with a six-lancet drum. It offers the least painful testing, with les
Medicine Products: